The Icos Alumni: Where Are They Now?
Luke Timmerman11/18/09Comments (4)Follow @ldtimmerman
(Page 3 of 9)
—Ardelle Dennis, executive assistant, CMC Icos
—Mike Dennis, pharmaceuticals professional
—Frank Diaz, assistant professor, University of North Alabama
—Ken Dick, senior field technical specialist, LI-COR Biosciences
—Greg Dietsch, vice president of research, VentiRx Pharmaceuticals
—Tressa Dodd, senior director of regulatory affairs, VentiRx Pharmaceuticals
—Jason Douangpanya, senior associate scientist, Amgen
—Heather Douangpanya, senior associate scientist, Amgen
—Tom Dudler, senior group leader, Omeros
—Christian Eckhoff, senior scientist at SNBL USA
—Ana Edwards, senior quality control analyst, Seattle Genetics
—Kevin Egan, vice president of business development, CMC Icos
—Fred Elliott, chemist, Bio-Rad Laboratories
—Leslie Elliott, clinical research consultant
—Nancy Enselman, office manager, VentiRx Pharmaceuticals
—Angela Epp, research technologist III, Puget Sound Blood Center
—James Esselstyn, production supervisor, Bio-Rad Laboratories
—Jerry Evarts, principal scientist, chemistry, Calistoga Pharmaceuticals
—Russell Eyre, director of safety assessment, SNBL USA
—Gay Fanning, marketing assistant
—Brian Farnes, safety coordinator, Nintendo
—Rebekah Farnsworth, senior manager of technology transfer, Alder Biopharmaceuticals
—Francine Farouz, senior director of medicinal chemistry, Fate Therapeutics
—Valerie Fauvelle, associate manager of regulatory affairs, Gilead Sciences
—Dave Federighi, senior analytical chemist, WIL Research Laboratories
—Ken Ferguson, president and CEO, Imvaxyn
—Gail Ferrari, executive assistant, business development, PopCap Games
—Lacy Fitzpatrick, senior investor relations analyst, Nordstrom
—Tim Fitzpatrick, site manager, Saltigo Redmond
—Vince Florio, director of science, Omeros
—Stephanie Florio, senior scientist, Infectious Disease Research Institute … Next Page »
Luke Timmerman is the National Biotech Editor of Xconomy, and the Editor of Xconomy Seattle. E-mail him at ltimmerman@xconomy.com or follow him on Twitter at twitter.com/ldtimmerman.
Johnny T. Stine
11/18/09 1:48 pm
I actually loved our logo – very simple, but it just looked like fun.
When George R. was recently asked by a reporter from an Everett newspaper about building Icos into a company like Amgen….he replied “…..why would I stop there?”. With a leader like that, like George, one who inspires with energetic goals such as that mentioned – we could’ve done it. We had the tools and the ability to do just that. We had great people who’ve all proven themselves in places before and afterward…….but imagine what we could’ve done behind the hopes of a great leader like George who set that tone….a CEO who knew all of our names, someone who would talk to you like you were a valued asset, a guy that empowered us via ownership. Imagine what we could’ve done…..because that’s all we’re left to do.
By the way- Luke – I prefer Icosanoids – a play on the word eicosanoid since we were primarily an inflammation company. :-)
Luke Timmerman
11/18/09 2:04 pm
Johnny—Unfortunately, I never really got to know George very well because he had already left Icos by the time I started covering the company in 2001. But I made a point of meeting him at his home once a couple years ago when I was based in San Francisco. He wasn’t in great health, but he was still sharp and very much curious about the latest happenings in biotech.
I haven’t heard the term Icosanoids from eicosanoid, but that made me laugh this morning. It sounds like something from Star Trek. Anybody know if this was also the inspiration for the term “Immunoids” for people who used to work at Immunex?
David Miller
11/23/09 2:54 pm
Nice work, Luke. Goes to prove that even though we might lose companies through acquisition we’d really rather keep, it’s not like everything connected with the company disappears. By my eye, the “loss” of Icos created at least a half-dozen new companies and significantly strengthened a dozen or more startups. A nice silver lining.
Abby Kliphardt
3/3/10 10:19 am
Nice article…good to see where my co-workers have ended. I loved my time at ICOS and will always lament the loss of a great company that was a real family….